QMS Medical Allied Services P/B Ratio
QMS Medical Allied Services P/B ratio. QMS Medical Allied Services (QMSMEDI) P/B ratio is 4.02 (High), book value per share ₹60.00 vs Healthcare average P/B of 0.01 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see QMS Medical Allied Services screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
QMSMEDI P/B Ratio — Valuation Insights & Book Value Analysis
QMS Medical Allied Services price-to-book ratio interpretation, valuation status and historical context — current P/B 4.02 (High). Analyse QMS Medical Allied Services shareholding analysis to track promoter, FII and institutional holdings.
- Stock appears overvalued with PB of 4.02, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 82.7% above historical average
- Trading at premium to sector average PB of 0.01
QMS Medical Allied Services P/B Ratio Historical Trend
QMSMEDI annual price-to-book ratio — 1 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View QMSMEDI price range for the annual high/low range and current price position.
QMSMEDI Historical P/B Ratio — Book Value Per Share & Year-End Price
QMS Medical Allied Services annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 2.2 | ₹60.0 | ₹131.92 | ₹114 | Moderate |
QMSMEDI vs Healthcare Peers — P/B Ratio Comparison
QMS Medical Allied Services P/B 4.02 vs Healthcare average 0.01, median 0.61 — range -6.55–1.07.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.19 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |